Stopping tumour necrosis factor-targeted biological DMARDs in rheumatoid arthritis
نویسندگان
چکیده
منابع مشابه
Salmonella enterica arthritis in a patient with rheumatoid arthritis receiving anti-tumour necrosis factor therapy.
Anti-tumour necrosis factor (TNF) monoclonal antibodies have become an invaluable treatment against chronic inflammatory diseases such as rheumatoid arthritis (RA). However, due to increased risk of opportunistic infections, patients receiving anti-TNF therapy should be closely monitored for serious infections. Here, we describe a case of acute Salmonella_enteritidis infection of a joint arthro...
متن کاملAnaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.
Anaemia of chronic disease (ACD) is a common feature of active rheumatoid arthritis (RA). Inflammatory cytokines, particularly tumour necrosis factor alpha (TNF-alpha), interleukin-1 (IL-1) and interleukin-6 (IL-6), are thought to contribute to the pathogenesis of ACD, possibly by inhibiting erythropoietin (EPO) production. In this study, we examined the in vivo effects of TNF-alpha blockade wi...
متن کاملTumour necrosis factor-alpha inhibitors help control symptoms in active rheumatoid arthritis
RA is a chronic progressive disabling autoimmune disease that occurs in 0.5% to 1% of the population. It is characterised by inflammation of the synovial tissue in the peripheral joints, which leads to swelling, stiffness, pain and progressive joint destruction. Life expectancy is also reduced and the impact of RA on quality of life should not be underestimated. About half of all patients are u...
متن کاملTumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis.
A large number of diseases are multifactorial whereby both environmental and genetic factors contribute to the aetiology and/or clinical severity. The genetics of many of these diseases is complex, involving multiple genes, and Mendelian patterns of inheritance do not apply. The genetic contribution in susceptibility for rheumatoid arthritis (RA) is exemplified by family clustering and a threef...
متن کاملAnti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.
Anti-TNFalpha therapy may have associated risks of serious infection, congestive heart failure, malignancy, and multiple sclerosis. The magnitude of these risks is difficult to assess. This article reviews publications on the current knowledge about the safety of these agents.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Rheumatology
سال: 2016
ISSN: 1462-0324,1462-0332
DOI: 10.1093/rheumatology/kew352